Daniel Fabricant, Ph.D., executive director and CEO, Natural Products Association (NPA), said FDA’s re-release of the new dietary ingredient (NDI) draft guidance will likely address the supplement’s industry concerns with synthetic botanicals, chemical alteration and a master file database.

November 19, 2014

Daniel Fabricant, Ph.D., executive director and CEO, Natural Products Association (NPA), said he can’t discuss specifics about what he expects will be in FDA’s re-release of the new dietary ingredient (NDI) draft guidance, but he said it will likely address the supplement’s industry concerns with synthetic botanicals, chemical alteration and a master file database.

NPA has committed to hosting a webinar within 72 hours of the release of the new NDI draft guidance, so in this video interview, INSIDER sat down with Fabricant at SupplySide West to discuss possible updates NPA expects to see.

Get more on NPA’s take on NDIs in the article “NDI Legislation and Alternatives” by Corey Hilmas, M.D., Ph.D., senior vice president of scientific and regulatory affairs, NPA.

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like